X
22Jan

Blog: Cooley’s 2020 Life Sciences M&A Year in Review

Cooley LLP | | Return|
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By: Cooley LLP
Source Url: https://www.jdsupra.com/legalnews/blog-cooley-s-2020-life-sciences-m-a-6599890/

Related

Caremark Round II: Beware Red Flags in Drug Development

On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent deci...

Read More >

HorrorFest 2020 Celebration: The Curse of Frankenstein and a Welcomed Safe Harbor

In this second edition of October HorrorFest 2020 celebration we consider the first Hammer film vers...

Read More >

City of San Antonio Enjoined From Enforcing Sick & Safe Leave Ordinance

On Friday, November 22, 2019, State District Judge Peter Sakai granted a temporary injunction enjoin...

Read More >

Construction During a Pandemic – Pillsbury’s 50-State Survey of COVID-19 Impact on Construction Services (UPDATED)

Pillsbury continues to track the impact on construction projects of COVID-19-related orders and guid...

Read More >

Tokyo Dispute Resolution & Crisis Management Newsletter – July 2019

Introduction - Owners and contractors involved in large-scale energy and manufacturing projects fac...

Read More >

SB75 Requires Employers To Disclose Judgments and Settlements

This alert is the fourth installment in our series on Illinois’ new anti-harassment legislation, SB...

Read More >